{
    "2018-06-13": [
        [
            {
                "time": "2018-03-15",
                "original_text": "ABBV Makes Notable Cross Below Critical Moving Average",
                "features": {
                    "keywords": [
                        "ABBV",
                        "notable cross",
                        "below",
                        "critical moving average"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "Notable ETF Inflow Detected - XLV, ABBV, AMGN, MDT",
                "features": {
                    "keywords": [
                        "ETF inflow",
                        "XLV",
                        "ABBV",
                        "AMGN",
                        "MDT"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-20",
                "original_text": "Humira's Sales Will Decline -- and It's Fantastic News for AbbVie",
                "features": {
                    "keywords": [
                        "Humira",
                        "sales decline",
                        "fantastic news",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-06-12",
                "original_text": "Humira's Sales Will Decline -- and It's Fantastic News for AbbVie",
                "features": {
                    "keywords": [
                        "Humira",
                        "sales decline",
                        "fantastic news",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}